Frontiers | Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms - Ming Li, 2016
Treatment-Resistant Schizophrenia Guideline | Psychiatrist.com
Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration | Journal of Medicinal Chemistry
Effect of N-acetylcysteine on clozapine-induced sialorrhea in schizophrenic patients: a case series
Pharmacokinetic simulations comparing acetylcysteine concentrations vs.... | Download Scientific Diagram
Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study - The Lancet Psychiatry
Vicks Drug of Choice List | PDF | Enzyme Inhibitor | Nonsteroidal Anti Inflammatory Drug
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review - ScienceDirect
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy | SpringerLink
Frontiers | Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions | Journal of Medicinal Chemistry
Criteria indicating treatment-resistant schizophrenia, and proxy... | Download Scientific Diagram
Geneesmiddelengebruik in de belgische rusthuizen en rust ... - KCE
Delaying clozapine: how long is too long? | General Psychiatry
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Assessing Psychiatric Adverse Effects during Clinical Drug Development | SpringerLink
Case study: treatment-resistant schizophrenia - The Pharmaceutical Journal
PDF) Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia | SpringerLink
